Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases

Clinical trial NCT07246096 · RECRUITING

Trial details

NCT number: NCT07246096
Sponsor: Changhai Hospital
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Autoimmune Diseases Systemic Lupus Erythematosus Systemic Sclerosis Primary Sjögren Syndrome Rheumatoid Arthritis Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Start date: 2026-02-20
Primary completion: 2027-07-20
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.